US 6211239
Method for treating or preventing breast cancer or leukemia using 6-[3-[1-adamantyl]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN)
expired A61KA61K31/192
Quick answer
US patent 6211239 (Method for treating or preventing breast cancer or leukemia using 6-[3-[1-adamantyl]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN)) held by Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma
- Grant date
- Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K31/192